Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease

BACKGROUND/AIMS: The efficacy of anti-tumor necrosis factor α (anti-TNFα) antibodies for postoperative Crohn's disease (CD) in patients who were treated with these agents prior to surgery is largely unknown. METHODS: CD patients who underwent intestinal resection and received anti-TNFα agents a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiraoka, Sakiko, Takashima, Shiho, Kondo, Yoshitaka, Inokuchi, Toshihiro, Sugihara, Yuusaku, Takahara, Masahiro, Kawano, Seiji, Harada, Keita, Kato, Jun, Okada, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797275/
https://www.ncbi.nlm.nih.gov/pubmed/29422801
http://dx.doi.org/10.5217/ir.2018.16.1.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797275/
https://www.ncbi.nlm.nih.gov/pubmed/29422801
http://dx.doi.org/10.5217/ir.2018.16.1.75

Ejemplares similares